It's exciting to hear a lot of positives trending the right way, but if you strip away the "promises", we still don't have financing in place, and we don't have anything approved. It's always nice to see a 50 cent runup because we suffer through the negative runs just as often.
No sense getting all worked up right now because it does appear as if we'll see where we stand on COVID in 45-60 days. Approval puts us at a different level, and denial sends us backwards significantly. Short of financing (can't uplist til financed), the FDA response to our COVID trials is the thing that matters in Q2/3.
News 
Market Data 
Discover 
